Valuation: Sumitomo Pharma Co., Ltd.

Capitalization 433B 2.92B 2.51B 2.33B 2.17B 4.01B 252B 4.47B 28.2B 10.65B 118B 10.95B 10.73B P/E ratio 2026 *
9x
P/E ratio 2027 * 22.9x
Enterprise value 645B 4.35B 3.73B 3.48B 3.23B 5.97B 374B 6.66B 41.99B 15.85B 176B 16.31B 15.97B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.66x
Free-Float
42.39%
Yield 2026 *
-
Yield 2027 * 0.34%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.96%
1 week+7.70%
Current month+12.36%
1 month+8.99%
3 months+54.10%
6 months+98.36%
Current year+93.78%
More quotes
1 week 988
Extreme 988
1,122
1 month 877
Extreme 877
1,122
Current year 500
Extreme 500
1,122
1 year 401
Extreme 401
1,122
3 years 279
Extreme 279
1,171
5 years 279
Extreme 279
2,363
10 years 279
Extreme 279
4,135
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2024-06-24
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 64 2025-06-24
Director/Board Member 64 2016-05-31
Director/Board Member 61 2018-05-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.96%+7.70%+157.92%+2.06% 2.92B
+1.34%-2.69%-10.00%+136.58% 693B
+0.44%+4.33%+5.82%-4.65% 394B
-1.12%-1.66%+9.83%+26.39% 334B
-2.22%-5.55%-53.26%-1.90% 287B
+0.58%+0.66%-7.15%-21.43% 259B
-1.12%-4.09%-2.94%+12.40% 223B
-0.17%-1.49%-15.11%-7.23% 215B
-1.91%-4.08%-36.42%-13.43% 201B
-1.17%-0.17%-11.03%+19.18% 158B
Average -0.34%-0.80%+3.77%+14.80% 276.78B
Weighted average by Cap. -0.22%-1.65%-11.20%+35.07%
See all sector performances

Financials

2026 *2027 *
Net sales 371B 2.5B 2.14B 2B 1.86B 3.43B 215B 3.83B 24.11B 9.1B 101B 9.37B 9.17B 376B 2.53B 2.17B 2.02B 1.88B 3.47B 218B 3.88B 24.45B 9.23B 102B 9.5B 9.3B
Net income 48.15B 324M 278M 259M 241M 445M 27.94B 497M 3.13B 1.18B 13.1B 1.22B 1.19B 18.96B 128M 110M 102M 95.02M 175M 11B 196M 1.23B 466M 5.16B 479M 469M
Net Debt 212B 1.43B 1.23B 1.14B 1.06B 1.96B 123B 2.19B 13.79B 5.21B 57.66B 5.36B 5.24B 189B 1.28B 1.09B 1.02B 949M 1.75B 110B 1.96B 12.32B 4.65B 51.53B 4.79B 4.69B
More financial data * Estimated data
Logo Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The Company operates its business through four segments. The Japan segment is engaged in the manufacture, purchase, and sale of ethical drugs. The North American segment is engaged in the manufacture, purchase, and sale of ethical drugs and conducts research and development in the areas of oncology, urology, respiratory disease, and regenerative cell medicine. The China segment is engaged in the manufacture (small packaged products) and sale of ethical pharmaceuticals. The Overseas Others segment is engaged in the manufacture and sale of ethical pharmaceuticals in Europe. The segment also purchase and sell ethical pharmaceuticals in Southeast Asia and Taiwan, as well as provide information and collection activities for the Company's products. Other business includes manufacturing, purchasing, and sales of food ingredients, food additives and chemical product materials.
Employees
3,832
More about the company
Date Price Change Volume
25-07-18 1,091.00 ¥ +1.96% 10,104,700
25-07-17 1,070.00 ¥ +4.80% 7,118,300
25-07-16 1,021.00 ¥ +0.49% 4,731,400
25-07-15 1,016.00 ¥ -1.55% 5,801,100
25-07-14 1,032.00 ¥ +1.88% 5,246,500

Delayed Quote Japan Exchange, July 18, 2025 at 02:30 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
1,091.00JPY
Average target price
797.50JPY
Spread / Average Target
-26.90%
Consensus

Quarterly revenue - Rate of surprise